News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
491,650 Results
Type
Article (30672)
Company Profile (133)
Press Release (460845)
Section
Business (158907)
Career Advice (1669)
Deals (25539)
Drug Delivery (87)
Drug Development (60494)
Employer Resources (113)
FDA (11206)
Job Trends (11134)
News (261875)
Policy (23935)
Tag
Academia (1667)
Alliances (41766)
Alzheimer's disease (885)
Approvals (11180)
Artificial intelligence (112)
Bankruptcy (232)
Best Places to Work (8492)
Breast cancer (90)
Cancer (770)
Cardiovascular disease (75)
Career advice (1422)
Cell therapy (163)
Clinical research (48516)
Collaboration (326)
Compensation (87)
COVID-19 (1764)
C-suite (73)
Data (861)
Diabetes (121)
Diagnostics (3941)
Drug pricing (77)
Earnings (65445)
Employer resources (102)
Events (74885)
Executive appointments (249)
FDA (11582)
Funding (238)
Gene therapy (141)
GLP-1 (457)
Government (2889)
Healthcare (11913)
Infectious disease (1813)
Inflammatory bowel disease (88)
Interviews (289)
IPO (11329)
Job creations (2983)
Job search strategy (1209)
Layoffs (286)
Legal (6018)
Lung cancer (123)
Manufacturing (157)
Medical device (7349)
Medtech (7354)
Mergers & acquisitions (14287)
Metabolic disorders (318)
Neuroscience (1095)
NextGen Class of 2024 (4254)
Non-profit (2931)
Northern California (987)
Obesity (181)
Opinion (180)
Patents (77)
People (42679)
Phase I (14109)
Phase II (20905)
Phase III (17156)
Pipeline (421)
Podcasts (69)
Policy (70)
Postmarket research (2211)
Preclinical (6105)
Radiopharmaceuticals (196)
Rare diseases (166)
Real estate (4267)
Regulatory (15944)
Research institute (1611)
Resumes & cover letters (248)
Southern California (930)
Startups (2483)
United States (9505)
Vaccines (377)
Weight loss (134)
Date
Today (86)
Last 7 days (599)
Last 30 days (2858)
Last 365 days (26048)
2024 (23930)
2023 (28728)
2022 (37453)
2021 (39580)
2020 (38307)
2019 (32411)
2018 (24516)
2017 (24367)
2016 (23789)
2015 (27575)
2014 (23027)
2013 (20068)
2012 (20617)
2011 (20550)
2010 (19252)
Location
Africa (675)
Arizona (89)
Asia (31250)
Australia (4722)
California (2229)
Canada (944)
China (189)
Colorado (117)
Connecticut (114)
Europe (67897)
Florida (365)
Georgia (82)
Illinois (236)
Indiana (166)
Maryland (371)
Massachusetts (1866)
Michigan (97)
Minnesota (158)
New Jersey (755)
New York (704)
North Carolina (565)
Northern California (987)
Ohio (90)
Pennsylvania (611)
South America (947)
Southern California (930)
Texas (321)
Washington State (246)
491,650 Results for "gan and lee pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association’s 84th Scientific Sessions
Gan & Lee Pharmaceuticals announced the presentation of three abstracts featuring their investigational products at the American Diabetes Association’s 84th Scientific Sessions.
June 17, 2024
·
3 min read
Pharm Country
Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association’s 84th Scientific Sessions
Gan & Lee Pharmaceuticals announced the results of the Phase 1b/2a clinical study of the Company’s independently developed glucagon-like peptide-1 receptor agonist, GZR18 Injection, in an obese/overweight population in China, along with the results of two other innovative insulins’ preclinical studies in poster presentations at the American Diabetes Association’s（ADA’s）84th Scientific Sessions.
June 22, 2024
·
7 min read
Press Releases
ObesityWeek®️ 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults
November 11, 2024
·
5 min read
Press Releases
Gan & Lee Pharmaceuticals’ Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies
October 15, 2024
·
8 min read
Press Releases
Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks
November 12, 2024
·
4 min read
Press Releases
Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)
September 16, 2024
·
6 min read
Press Releases
Gan & Lee Pharmaceuticals’ Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial
July 22, 2024
·
4 min read
Business
Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
Invivyd, Inc. today announced that Timothy Lee will be appointed Invivyd’s Chief Commercial Officer and will join the company’s executive leadership team.
May 31, 2024
·
10 min read
Drug Development
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)
Gan & Lee Pharmaceuticals Co., Ltd. is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin glargine (GL-GLA) to a reference biologic.
October 14, 2021
·
2 min read
Business
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
TFF Pharmaceuticals, Inc. today announced that Catherine Lee, J.D. has been appointed to its Board of Directors.
November 30, 2023
·
6 min read
1 of 49,165
Next
